Advertisement

  • Published Date

    July 10, 2020
    Learn More, Click Here.

Ad Text

Business Insight How to live and behave in the times of pandemic... If you think I will give you a perfect answer and direction to the title, you are wrong. Doctors base their knowledge on science and standards of care for diagnosis and indications. They do not have a magic ball how to answer questions of diseases that are new and keep evolving. Being a doctor-researcher helps me keep my mind open and allows for a better acceptance of novel options of treatment. But it also makes me more cautious. Simply, because I know how exactly drugs and vaccines are developed, I do not jump for joy seeing what has been happening in our development market. Lots of it seems too rushed, too focus on financial gains, and too general to be considered scientific. Many drugs that begin the phase 1 those who finished the study only development go not much further. Phase 2 offers a little more assurance but only phase that need to be answered before we really 3 allows for proper gathering of research know we can start using a new drug or data on a large sample of patients to assess safety and efficacy of the new medication. Any rush will cause cutting edges in the injections and I have experienced all the process and that will result in safety risks. phases of research by statistical numbers What worries me is that our financial market These are just some logical questions vaccine. How do I know? I have done over 250 studies that included serious biologic but mostly, by live patients who were observed, examined, and treated. In the meantime, before we actually come with a safe remedy, let's just all follow common sense of protection. This does not harm or hurt anyone. We can go to work, we can go to grocery stores, we can enjoy a walk proves over and over that their emotional reaction to some statement of 'success' is based on an empty wording rather than actual data. Nobody seems to even care about what success of a new drug means. And it should be scrutinized. Let me give you some tips for what I or jog. Let's just wear masks. Let's distance would like to know about the on-going our interactions. Let's avoid unknown trials. Here are some questions I would ask: -how big was your sample of patients -how diverse was your sample: by gender, is really up to us and not the government age, medical history, life style history, ethnic to stay healthy and well. Do not wait for background -what was a rate of placebo versus real your common sense and think about how drug -how many patients started the study and how many finished -how many patients experienced adverse that one quarter of people who seek a test events and how many were serious, causing actually are positive. Hospitals are out of hospitalization or death -how did you expose the patients' group staff. Patients are being transferred out of to the actual virus - for the studies of state to get help. vaccines -what was the efficacy-positive response rate, considering a number of patients who were enrolled in the study in totals and not groups and gatherings. Let's limit social group interactions in person. This time, it directions and do not expect miracles. Use much you are risking by not doing that. It was announced today that Arizona has a 25% positive rate in testing. This means beds. There is a 100% utilization of medical Do not take the risk this time. Stay healthy. Michael Bukhalo, MD Arlington Dermatology 5301 Keystone Court Rolling Meadows, IL 60008 Tel. 847 392 5440 | www.arlingtondermatology.net Business Insight How to live and behave in the times of pandemic... If you think I will give you a perfect answer and direction to the title, you are wrong. Doctors base their knowledge on science and standards of care for diagnosis and indications. They do not have a magic ball how to answer questions of diseases that are new and keep evolving. Being a doctor-researcher helps me keep my mind open and allows for a better acceptance of novel options of treatment. But it also makes me more cautious. Simply, because I know how exactly drugs and vaccines are developed, I do not jump for joy seeing what has been happening in our development market. Lots of it seems too rushed, too focus on financial gains, and too general to be considered scientific. Many drugs that begin the phase 1 those who finished the study only development go not much further. Phase 2 offers a little more assurance but only phase that need to be answered before we really 3 allows for proper gathering of research know we can start using a new drug or data on a large sample of patients to assess safety and efficacy of the new medication. Any rush will cause cutting edges in the injections and I have experienced all the process and that will result in safety risks. phases of research by statistical numbers What worries me is that our financial market These are just some logical questions vaccine. How do I know? I have done over 250 studies that included serious biologic but mostly, by live patients who were observed, examined, and treated. In the meantime, before we actually come with a safe remedy, let's just all follow common sense of protection. This does not harm or hurt anyone. We can go to work, we can go to grocery stores, we can enjoy a walk proves over and over that their emotional reaction to some statement of 'success' is based on an empty wording rather than actual data. Nobody seems to even care about what success of a new drug means. And it should be scrutinized. Let me give you some tips for what I or jog. Let's just wear masks. Let's distance would like to know about the on-going our interactions. Let's avoid unknown trials. Here are some questions I would ask: -how big was your sample of patients -how diverse was your sample: by gender, is really up to us and not the government age, medical history, life style history, ethnic to stay healthy and well. Do not wait for background -what was a rate of placebo versus real your common sense and think about how drug -how many patients started the study and how many finished -how many patients experienced adverse that one quarter of people who seek a test events and how many were serious, causing actually are positive. Hospitals are out of hospitalization or death -how did you expose the patients' group staff. Patients are being transferred out of to the actual virus - for the studies of state to get help. vaccines -what was the efficacy-positive response rate, considering a number of patients who were enrolled in the study in totals and not groups and gatherings. Let's limit social group interactions in person. This time, it directions and do not expect miracles. Use much you are risking by not doing that. It was announced today that Arizona has a 25% positive rate in testing. This means beds. There is a 100% utilization of medical Do not take the risk this time. Stay healthy. Michael Bukhalo, MD Arlington Dermatology 5301 Keystone Court Rolling Meadows, IL 60008 Tel. 847 392 5440 | www.arlingtondermatology.net